Lv51
824 积分 2024-03-15 加入
Real-world efficacy and safety of ritlecitinib combined with phototherapy in refractory vitiligo: A single-center experience
5天前
已关闭
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
5天前
已完结
Comparative clinical, trichoscopic and safety outcomes of baricitinib, ritlecitinib and upadacitinib in alopecia areata: a real-world experience
5天前
已完结
Real-world efficacy and safety of ritlecitinib in alopecia areata: A single-centre experience
5天前
已完结
Oral ritlecitinib for the treatment of refractory vitiligo: A retrospective study
5天前
已完结
Efficacy and safety of switching from baricitinib to ritlecitinib in severe alopecia areata
5天前
已完结
Ovarian Cancer: Primary Advanced and Recurrent Disease
12天前
已完结
Ovarian Cancer: Primary Advanced and Recurrent Disease
12天前
已关闭
An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and Beyond
1个月前
已完结
Real-world pharmacovigilance analysis of depression associated with antineoplastic agents
1个月前
已完结
皖公网安备34019202002308
